Scarica l'app Stockscreener
3.90
1.02%
-0.04
Pre-mercato:
3.77
-0.13
-3.33%
Rezolute Inc Borsa (RZLT) Ultime notizie
Rezolute Inc (NASDAQ: RZLT) Share Price, RZLT Stock News, RZLT Share Price & Updates - kalkine.ca
Rezolute, Inc. (RZLT) Stock Price, News, Quote & History - Yahoo! Finance Canada
RZLT Maintained by HC Wainwright & Co. -- Price Target Raised to $10 - GuruFocus
Rezolute (NASDAQ:RZLT) Given New $10.00 Price Target at HC Wainwright - MarketBeat
HC Wainwright & Co. maintains Buy rating on Rezolute, $10 price target - TradingView
Citizens reiterates Rezolute stock rating on tumor trial results due By Investing.com - Investing.com Canada
Citizens reiterates Rezolute stock rating on tumor trial results due - Investing.com
Rezolute highlights ENDO data on congenital HI outcomes and tumor HI case series - scanx.trade
Rezolute Inc (RZLT) Faces Valuation Challenges Amid Cash Burn an - GuruFocus
Rezolute Q4FY26 Results: EPS misses estimate at $(0.20), net loss narrows - scanx.trade
Rezolute, Inc. FY 2026: Revenue $0 Net loss $77.6M, EPS $(0.75) — 10-K Summary - TradingView
Rezolute Fiscal Q4 Loss Narrows - marketscreener.com
Rezolute reports FY2026 net loss $77.6M, cash and investments $107.8M as of June 30, 2026 - TradingView
Rezolute Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results and Provides Business Update - The Manila Times
Rezolute Reports $20.5 Million Fourth-Quarter Loss and $107.8 Million Cash - Quiver Quantitative
Rezolute Q4 net loss narrows as R&D expenses fall - TradingView
Press Release: Rezolute Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results and Provides Business Update - Moomoo
Rezolute Inc (RZLT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Should I Buy RZLT? RZLT 2026 AnalysisIntellectia AI™ - intellectia.ai
Rezolute Inc. (RZLT) Q2 2026 Earnings: Narrower-Than-Expected Loss Offers Modest BeatOne-Time Loss Impact - careplusvn.com
Rezolute Inc. (NV) (RZLT) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Weekly Recap: Strong retention in sunRIZE extension and buy‑tilt at $6 - TradingView
Rezolute, Inc. expected to post a loss of 15 cents a shareEarnings Preview - TradingView
Rezolute: Initiating At Sell Despite Attempts To Rescue Ersodetug Following sunRIZE Upset - Seeking Alpha
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Rezolute (RZLT) FDA Review Highlights Uncertain Path Amid Cash-F - GuruFocus
Rezolute says late-stage trial data for lead asset remains under FDA review - TradingView
Rezolute awaits FDA feedback on congenital HI treatment data By Investing.com - Investing.com Nigeria
Rezolute FDA Review Continues After Phase 3 sunRIZE Study Missed Primary Endpoint - Yahoo Finance
Rezolute (RZLT) Updates FDA Review of Phase 3 Data Amid Unprofitable Status - GuruFocus
Rezolute awaits FDA feedback on congenital HI treatment data - investing.com
Rezolute Provides Update on FDA Review of its Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism - The Manila Times
RZLT Q4'26 Earnings: EPS estimate is (0.15) USD - TradingView
FDA is still reviewing Rezolute’s experimental drug. No timeline is set. - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Rezolute Stock Price Forecast. Should You Buy RZLT? - StockInvest.us
Rezolute (RZLT) CCO sells stock to cover RSU taxes - stocktitan.net
RZLT Q4'26 Earnings: revenue estimate is 0 USD - tradingview.com
Rezolute (RZLT) Shares Decline 7% as Stock Approaches Key Support at $4.39Diagonal Spread Trade - vinanet.vn
Wedbush Maintains Rezolute(RZLT.US) With Buy Rating, Maintains Target Price $6 - Moomoo
Rezolute, Inc.'s (NASDAQ:RZLT) Shift From Loss To Profit - simplywall.st
Balyasny Asset Management L.P. Reduces Stake in Rezolute Inc (RZ - GuruFocus
Rezolute, Inc. (NASDAQ:RZLT) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Rezolute Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Bank of New York Mellon Corp Sells 481,913 Shares of Rezolute, Inc. $RZLT - MarketBeat
Balyasny reports 4.84% Rezolute (RZLT) stake in Schedule 13G/A - Stock Titan
Rezolute, Inc. $RZLT Shares Acquired by Dimensional Fund Advisors LP - MarketBeat
Bank of America Corp (RZLT) discloses 1.2% Rezolute ownership in 13G/A - Stock Titan
Rezolute, Inc. (RZLT) gains 5.9% reported stake from Dellora Investments - Stock Titan
Rezolute Inc (RZLT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Rezolute Inc (RZLT) Stock News Today - TradingKey
INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - The National Law Review
RZLT Q2 2026 Earnings: Loss Narrows 12.33% vs. Estimates; Shares Slip 3.28%Downward Estimate Revision - careplusvn.com
Rezolute (RZLT) Pulls Back 5.4% as Biotech Volatility ResurfacesAggressive Growth Picks - vinanet.vn
H.C. Wainwright reiterates Rezolute stock rating at buy, $5 target - Investing.com
H.C. Wainwright Maintains Rezolute(RZLT.US) With Buy Rating, Maintains Target Price $5 - moomoo.com
RZLT|Rezolute Inc|Price:4.930|Chg%:-0.060 - TradingKey
RZLT|Rezolute Inc|Price:4.990| - TradingKey
Rezolute Inc (RZLT) Balance Sheet - TradingKey
Rezolute Inc (RZLT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Rezolute Inc (RZLT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Rezolute Inc (RZLT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
3.06%
2.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):